These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 9295871)
1. [Oxaliplatin: the first DACH platinum in clinical practice]. Soulié P; Raymond E; Brienza S; Cvitkovic E Bull Cancer; 1997 Jun; 84(6):665-73. PubMed ID: 9295871 [TBL] [Abstract][Full Text] [Related]
2. Oxaliplatin: a review of preclinical and clinical studies. Raymond E; Chaney SG; Taamma A; Cvitkovic E Ann Oncol; 1998 Oct; 9(10):1053-71. PubMed ID: 9834817 [TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Culy CR; Clemett D; Wiseman LR Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200 [TBL] [Abstract][Full Text] [Related]
4. [Oxaliplatin: a first DACH-platinum in oncology]. Laadem A; Cvitkovic E Bull Cancer; 2001 Aug; 88 Spec No():S9-13. PubMed ID: 11567908 [TBL] [Abstract][Full Text] [Related]
6. Oxaliplatin (L-OHP): a new reality in colorectal cancer. Bleiberg H Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):1-3. PubMed ID: 9647611 [TBL] [Abstract][Full Text] [Related]
7. Ongoing and unsaid on oxaliplatin: the hope. Cvitkovic E Br J Cancer; 1998 Jun; 77 Suppl 4(Suppl 4):8-11. PubMed ID: 9647613 [TBL] [Abstract][Full Text] [Related]
8. Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer. Chollet P; Bensmaïne MA; Brienza S; Deloche C; Curé H; Caillet H; Cvitkovic E Ann Oncol; 1996 Dec; 7(10):1065-70. PubMed ID: 9037366 [TBL] [Abstract][Full Text] [Related]
9. Platinum compounds in the treatment of advanced breast cancer. Martín M Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413 [TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin in tumors other than colorectal cancer. Lorusso PM Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):33-7. PubMed ID: 11204661 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin salvage for recurrent ovarian cancer: a single institution's experience in patient populations with platinum resistant disease or a history of platinum hypersensitivity. Taylor SE; Beck TL; Krivak TC; Zorn KK; Kelley JL; Edwards RP Gynecol Oncol; 2014 Jul; 134(1):68-72. PubMed ID: 24769036 [TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin: a review of its use in combination therapy for advanced metastatic colorectal cancer. Simpson D; Dunn C; Curran M; Goa KL Drugs; 2003; 63(19):2127-56. PubMed ID: 12962525 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of oxaliplatin monotherapy: phase II trials in advanced colorectal cancer. Becouarn Y; Rougier P Semin Oncol; 1998 Apr; 25(2 Suppl 5):23-31. PubMed ID: 9609105 [TBL] [Abstract][Full Text] [Related]
15. Carboplatin in the first-line chemotherapy of ovarian cancer. Alberts DS; Canetta R; Mason-Liddil N Semin Oncol; 1990 Feb; 17(1 Suppl 2):54-60. PubMed ID: 2406922 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers. Raymond E; Buquet-Fagot C; Djelloul S; Mester J; Cvitkovic E; Allain P; Louvet C; Gespach C Anticancer Drugs; 1997 Oct; 8(9):876-85. PubMed ID: 9402315 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin: a novel platinum analog with activity in colorectal cancer. Berg D Oncol Nurs Forum; 2003; 30(6):957-66. PubMed ID: 14603353 [TBL] [Abstract][Full Text] [Related]
18. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells. Serova M; Calvo F; Lokiec F; Koeppel F; Poindessous V; Larsen AK; Laar ES; Waters SJ; Cvitkovic E; Raymond E Cancer Chemother Pharmacol; 2006 Apr; 57(4):491-9. PubMed ID: 16075278 [TBL] [Abstract][Full Text] [Related]
19. [Role and value of oxaliplatin in metastatic colorectal cancers]. Louvet C; de Gramont A Rev Med Interne; 1997; 18 Suppl 4():368s-371s. PubMed ID: 9365714 [TBL] [Abstract][Full Text] [Related]
20. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study. Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]